Why Inovio Pharmaceuticals Inc. Is Sinking Today

In response to the company reporting disappointing third-quarter results, shares of Inovio Pharmaceuticals (NASDAQ: INO), a clinical-stage biotech focused on vaccines, fell 14% as of 2:15 p.m. EST on Thursday.

Here's a review of the headline numbers from the quarter:

Looking beyond the financials, here's a quick overview of some of the company's recent clinical news:

Source: Fool.com